Extension of the intensive phase reduces relapse but not failure in a regimen with rifampicin throughout

Extension of P1 is very inefficient with this 6-month regimen. Operational research should define appropriate algorithms allowing an earlier switch to the next higher regimen for those in need, using follow-up smears for screening.